WeVote

Bill

Bill

HB 6599

AN ACT CONCERNING SOURCE PLASMA DONATION CENTERS.

2025 Regular Session Introduced by Christie Carpino and 1 co-sponsor

Connecticut bill establishing state regulation and safety standards for blood plasma donation centers to ensure donor protection and facility compliance.

REF. TO JOINT COMM. ON Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 6599

Legislative bill overview

HB 6599 establishes regulatory requirements and operational standards for source plasma donation centers in Connecticut. The bill addresses licensing, facility standards, donor safety protocols, and oversight mechanisms for facilities that collect blood plasma from donors, typically for pharmaceutical manufacturing and medical treatments.

Why is this important

Source plasma donation centers operate in a largely unregulated market in many states, raising public health concerns about donor screening, facility sanitation, and compensation practices. This bill would bring Connecticut's plasma collection industry under state health department oversight, potentially affecting both the availability of plasma for medical use and the working conditions of plasma donors, many of whom are economically vulnerable populations.

Potential points of contention

  • Donor compensation limits: Regulations may cap payment for plasma donations, which could reduce donor participation and affect the plasma supply chain, or conversely, protect vulnerable populations from exploitative compensation practices
  • Facility compliance costs: New licensing and safety standards could increase operational costs for centers, potentially reducing their number or profitability versus improving public health protections
  • Definition of "source plasma" and scope: Disagreement over which facilities fall under regulation and what specific standards apply could create enforcement challenges or unintended loopholes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.